Literature DB >> 24362699

The mouse model of respiratory syncytial virus disease.

Peter J Openshaw1.   

Abstract

The laboratory mouse is the species of choice for most immunological studies, ranging from simple vaccine testing to the intricate dissection of fundamental immunopathogenic mechanisms. Although not fully mouse adapted, some strains of respiratory syncytial virus (RSV) replicate in the murine respiratory tract and induce specific T and B cell responses. Passive transfer of neutralising antibody is protective and assist in viral clearance. In addition, many of RSV's complex behaviours are recapitulated in the mouse (including enhancement of disease by vaccination and delayed effects of neonatal infection). However, human studies remain essential to confirm or refute predictions from animal models.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362699     DOI: 10.1007/978-3-642-38919-1_18

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  17 in total

Review 1.  Animal models of respiratory syncytial virus infection and disease.

Authors:  Randy E Sacco; Russell K Durbin; Joan E Durbin
Journal:  Curr Opin Virol       Date:  2015-07-11       Impact factor: 7.090

2.  Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization.

Authors:  Simon D van Haren; David J Dowling; Willemina Foppen; Dennis Christensen; Peter Andersen; Steven G Reed; Robert M Hershberg; Lindsey R Baden; Ofer Levy
Journal:  J Immunol       Date:  2016-10-28       Impact factor: 5.422

Review 3.  Determinants of early life immune responses to RSV infection.

Authors:  Tracy J Ruckwardt; Kaitlyn M Morabito; Barney S Graham
Journal:  Curr Opin Virol       Date:  2016-03-15       Impact factor: 7.090

4.  T-Cell Responses in Adults During Natural Respiratory Syncytial Virus Infection.

Authors:  D Roumanes; A R Falsey; S Quataert; S Secor-Socha; F E-H Lee; H Yang; S Bandyopadhyay; J Holden-Wiltse; D J Topham; E E Walsh
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

5.  Reduced Nasal Viral Load and IFN Responses in Infants with Respiratory Syncytial Virus Bronchiolitis and Respiratory Failure.

Authors:  Ryan S Thwaites; Matthew Coates; Kazuhiro Ito; Marwa Ghazaly; Calandra Feather; Farhana Abdulla; Tanushree Tunstall; Pooja Jain; Lindsey Cass; Garth Rapeport; Trevor T Hansel; Simon Nadel; Peter Openshaw
Journal:  Am J Respir Crit Care Med       Date:  2018-10-15       Impact factor: 21.405

Review 6.  Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches.

Authors:  Sara A Taleb; Asmaa A Al Thani; Khalid Al Ansari; Hadi M Yassine
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-06       Impact factor: 3.267

7.  Mouse Models of Respiratory Syncytial Virus Infection.

Authors:  Zachary J Ceneviva; Allison E Norlander; R Stokes Peebles
Journal:  Methods Mol Biol       Date:  2022

Review 8.  Immunity to RSV in Early-Life.

Authors:  Laura Lambert; Agnes M Sagfors; Peter J M Openshaw; Fiona J Culley
Journal:  Front Immunol       Date:  2014-09-29       Impact factor: 7.561

Review 9.  Animal models of respiratory syncytial virus infection.

Authors:  Geraldine Taylor
Journal:  Vaccine       Date:  2016-11-29       Impact factor: 3.641

10.  Respiratory Syncytial Virus (RSV) Infects CD4+ T Cells: Frequency of Circulating CD4+ RSV+ T Cells as a Marker of Disease Severity in Young Children.

Authors:  Silvina Raiden; Inés Sananez; Federico Remes-Lenicov; Julieta Pandolfi; Cecilia Romero; Leonardo De Lillo; Ana Ceballos; Jorge Geffner; Lourdes Arruvito
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.